Inglese

The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 moduli  
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000372
Descrizione

pht000372

DUMMY ID NUMBER
Descrizione

ID2

Tipo di dati

string

Alias
UMLS CUI [1,1]
C2348585
ASSESSMENT PERIOD (ALL PARTICIPANTS)
Descrizione

VIS

Tipo di dati

string

Alias
UMLS CUI [1,1]
C1516048
UMLS CUI [1,2]
C1948053
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
DAILY DIETARY ESTIMATES OF CALORIES (ALL PARTICIPANTS)
Descrizione

DT_KCAL

Tipo di dati

float

Alias
UMLS CUI [1,1]
C0332173
UMLS CUI [1,2]
C0750572
UMLS CUI [1,3]
C0012155
UMLS CUI [1,4]
C1556156
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
TOTAL FAT (G) (ALL PARTICIPANTS)
Descrizione

DT_FAT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C3272929
UMLS CUI [1,2]
C2964552
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
CARBOHYDRATE (G) (ALL PARTICIPANTS)
Descrizione

DT_CARB

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0489461
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
CALCIUM (MG) (ALL PARTICIPANTS)
Descrizione

DT_CALC

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0006675
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
PHOSPHORUS (MG) (ALL PARTICIPANTS)
Descrizione

DT_PHOS

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0031705
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
IRON (MG) (ALL PARTICIPANTS)
Descrizione

DT_FE

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0302583
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
SODIUM (MG) (ALL PARTICIPANTS)
Descrizione

DT_NA

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0037473
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
POTASSIUM (MG) (ALL PARTICIPANTS)
Descrizione

DT_POTA

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0032821
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
VITAMIN A IU (IU) (ALL PARTICIPANTS)
Descrizione

DT_A_IU

Tipo di dati

float

Unità di misura
  • IU
Alias
UMLS CUI [1,1]
C1881234
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
IU
VITAMIN A RE (MCG) (ALL PARTICIPANTS)
Descrizione

DT_A_RE

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0042839
UMLS CUI [1,2]
C0556581
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
THIAMIN (MG) (ALL PARTICIPANTS)
Descrizione

DT_B1

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0039840
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
RIBOFLAVIN (MG) (ALL PARTICIPANTS)
Descrizione

DT_RIBO

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0035527
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
NIACIN (MG) (ALL PARTICIPANTS)
Descrizione

DT_NIAC

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0027996
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
VITAMIN C (MG) (ALL PARTICIPANTS)
Descrizione

DT_VITC

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0003968
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
TOTAL SATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descrizione

DT_SFAT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C2699272
UMLS CUI [1,2]
C0439810
UMLS CUI [1,3]
C1286104
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
OLEIC ACID (MUFA 18:1) (G) (ALL PARTICIPANTS)
Descrizione

DT_OLEC

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0028928
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
CHOLESTEROL (MG) (ALL PARTICIPANTS)
Descrizione

DT_CHOL

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0008377
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
FOLATE (MCG) (ALL PARTICIPANTS)
Descrizione

DT_FOL

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0016410
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
TOTAL VITAMIN E ACTIVITY (ALL PARTICIPANTS)
Descrizione

DT_VITE

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0439810
UMLS CUI [1,2]
C1142098
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
ZINC (MG) (ALL PARTICIPANTS)
Descrizione

DT_ZINC

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0043481
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
VITAMIN B6 (MG) (ALL PARTICIPANTS)
Descrizione

DT_B6

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0087162
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
MAGNESIUM (MG) (ALL PARTICIPANTS)
Descrizione

DT_MG

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0024467
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
ALPHA-CAROTENE (MCG) (ALL PARTICIPANTS)
Descrizione

DT_ACAR

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0042839
UMLS CUI [1,2]
C0053396
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
BETA-CAROTENE (MCG) (ALL PARTICIPANTS)
Descrizione

DT_BCAR

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0696105
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
BETA-CRYPTOXANTHIN (MCG) (ALL PARTICIPANTS)
Descrizione

DT_CRYP

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0043314
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
LUTEIN+ZEAXANTHIN (MCG) (ALL PARTICIPANTS)
Descrizione

DT_LUT

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0043314
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
LYCOPENE (MCG) (ALL PARTICIPANTS)
Descrizione

DT_LYC

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0065331
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
RETINOL (MCG) (ALL PARTICIPANTS)
Descrizione

DT_RET

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0042839
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
BETA-CAROTENE EQUIVALENTS (MCG) (ALL PARTICIPANTS)
Descrizione

DT_PROA

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0053396
UMLS CUI [1,2]
C0205163
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
VEGETABLE PROTEIN (G) (ALL PARTICIPANTS)
Descrizione

DT_VPROT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0033684
UMLS CUI [1,2]
C0042440
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
LINOLEIC ACID (PUFA 18:2) (G) (ALL PARTICIPANTS)
Descrizione

DT_PUFA182

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0032615
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
SOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
Descrizione

DT_SFIB

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0012173
UMLS CUI [1,2]
C0556108
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
ANIMAL PROTEIN (G) (ALL PARTICIPANTS)
Descrizione

DT_APROT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0033684
UMLS CUI [1,2]
C3494749
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
SELENIUM (MCG) (ALL PARTICIPANTS)
Descrizione

DT_SEL

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0036581
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
TOTAL POLYUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descrizione

DT_PUFA

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0439810
UMLS CUI [1,2]
C2700114
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
TOTAL MONOUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descrizione

DT_MUFA

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0439810
UMLS CUI [1,2]
C2700114
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
ALCOHOL (G) (ALL PARTICIPANTS)
Descrizione

DT_ALC

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
GALACTOSE (G) (ALL PARTICIPANTS)
Descrizione

DT_GAL

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0016945
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
LACTOSE (G) (ALL PARTICIPANTS)
Descrizione

DT_LACT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0022949
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
INSOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
Descrizione

DT_IFIB

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0012173
UMLS CUI [1,2]
C1298908
UMLS CUI [1,3]
C0037633
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
VITAMIN D (MCG) (ALL PARTICIPANTS)
Descrizione

DT_VITD

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0042866
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
VITAMIN B12 (MCG) (ALL PARTICIPANTS)
Descrizione

DT_B12

Tipo di dati

float

Unità di misura
  • micrograms
Alias
UMLS CUI [1,1]
C0042845
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
micrograms
COPPER (MG) (ALL PARTICIPANTS)
Descrizione

DT_CU

Tipo di dati

float

Unità di misura
  • milligrams
Alias
UMLS CUI [1,1]
C0009968
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
milligrams
EICOSAPENTAENOIC ACID (G) (ALL PARTICIPANTS)
Descrizione

EPA

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
DOCOSAHEXAENOIC ACID (G) (ALL PARTICIPANTS)
Descrizione

DHA

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
TRYPTOPHAN (G) (ALL PARTICIPANTS)
Descrizione

DT_TRYP

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0041249
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
METHIONINE (G) (ALL PARTICIPANTS)
Descrizione

DT_MET

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0025646
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
GLUTAMIN ACID (G) (ALL PARTICIPANTS)
Descrizione

DT_GLUT

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0017797
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
LINOLENIC ACID (G) (ALL PARTICIPANTS)
Descrizione

DT_PUFA183

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [1,2]
C2700114
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
ARACHIDONIC ACID (G) (ALL PARTICIPANTS)
Descrizione

DT_PUFA204

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0003695
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
YEARS FROM RANDOMIZATION TO DATE OF FOLLOW-UP ASSESSMENT (If available) (ALL PARTICIPANTS)
Descrizione

FFQTIME

Tipo di dati

float

Unità di misura
  • years
Alias
UMLS CUI [1,1]
C0439234
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C3694716
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
years
DIETARY GLYCEMIC LOAD (ALL PARTICIPANTS)
Descrizione

DGL

Tipo di dati

float

Alias
UMLS CUI [1,1]
C3267174
UMLS CUI [1,2]
C0012155
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
DIETARY GLYCEMIC INDEX (ALL PARTICIPANTS)
Descrizione

DGI

Tipo di dati

float

Alias
UMLS CUI [1,1]
C1136206
UMLS CUI [1,2]
C0012155
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
TOTAL AVAILABLE DIETARY CARBOHYDRATES (G) (ALL PARTICIPANTS)
Descrizione

TACHO

Tipo di dati

float

Unità di misura
  • grams
Alias
UMLS CUI [1,1]
C0439810
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C0007004
UMLS CUI [1,4]
C0012155
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
grams
Ritorna all'inizio della pagina

Similar models

The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 moduli
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
pht000372
ID2
Item
DUMMY ID NUMBER
string
C2348585 (UMLS CUI [1,1])
VIS
Item
ASSESSMENT PERIOD (ALL PARTICIPANTS)
string
C1516048 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_KCAL
Item
DAILY DIETARY ESTIMATES OF CALORIES (ALL PARTICIPANTS)
float
C0332173 (UMLS CUI [1,1])
C0750572 (UMLS CUI [1,2])
C0012155 (UMLS CUI [1,3])
C1556156 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_FAT
Item
TOTAL FAT (G) (ALL PARTICIPANTS)
float
C3272929 (UMLS CUI [1,1])
C2964552 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_CARB
Item
CARBOHYDRATE (G) (ALL PARTICIPANTS)
float
C0489461 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_CALC
Item
CALCIUM (MG) (ALL PARTICIPANTS)
float
C0006675 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PHOS
Item
PHOSPHORUS (MG) (ALL PARTICIPANTS)
float
C0031705 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_FE
Item
IRON (MG) (ALL PARTICIPANTS)
float
C0302583 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_NA
Item
SODIUM (MG) (ALL PARTICIPANTS)
float
C0037473 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_POTA
Item
POTASSIUM (MG) (ALL PARTICIPANTS)
float
C0032821 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_A_IU
Item
VITAMIN A IU (IU) (ALL PARTICIPANTS)
float
C1881234 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_A_RE
Item
VITAMIN A RE (MCG) (ALL PARTICIPANTS)
float
C0042839 (UMLS CUI [1,1])
C0556581 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_B1
Item
THIAMIN (MG) (ALL PARTICIPANTS)
float
C0039840 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_RIBO
Item
RIBOFLAVIN (MG) (ALL PARTICIPANTS)
float
C0035527 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_NIAC
Item
NIACIN (MG) (ALL PARTICIPANTS)
float
C0027996 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_VITC
Item
VITAMIN C (MG) (ALL PARTICIPANTS)
float
C0003968 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_SFAT
Item
TOTAL SATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
C2699272 (UMLS CUI [1,1])
C0439810 (UMLS CUI [1,2])
C1286104 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_OLEC
Item
OLEIC ACID (MUFA 18:1) (G) (ALL PARTICIPANTS)
float
C0028928 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_CHOL
Item
CHOLESTEROL (MG) (ALL PARTICIPANTS)
float
C0008377 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_FOL
Item
FOLATE (MCG) (ALL PARTICIPANTS)
float
C0016410 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_VITE
Item
TOTAL VITAMIN E ACTIVITY (ALL PARTICIPANTS)
float
C0439810 (UMLS CUI [1,1])
C1142098 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_ZINC
Item
ZINC (MG) (ALL PARTICIPANTS)
float
C0043481 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_B6
Item
VITAMIN B6 (MG) (ALL PARTICIPANTS)
float
C0087162 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_MG
Item
MAGNESIUM (MG) (ALL PARTICIPANTS)
float
C0024467 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_ACAR
Item
ALPHA-CAROTENE (MCG) (ALL PARTICIPANTS)
float
C0042839 (UMLS CUI [1,1])
C0053396 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_BCAR
Item
BETA-CAROTENE (MCG) (ALL PARTICIPANTS)
float
C0696105 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_CRYP
Item
BETA-CRYPTOXANTHIN (MCG) (ALL PARTICIPANTS)
float
C0043314 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_LUT
Item
LUTEIN+ZEAXANTHIN (MCG) (ALL PARTICIPANTS)
float
C0043314 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_LYC
Item
LYCOPENE (MCG) (ALL PARTICIPANTS)
float
C0065331 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_RET
Item
RETINOL (MCG) (ALL PARTICIPANTS)
float
C0042839 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PROA
Item
BETA-CAROTENE EQUIVALENTS (MCG) (ALL PARTICIPANTS)
float
C0053396 (UMLS CUI [1,1])
C0205163 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_VPROT
Item
VEGETABLE PROTEIN (G) (ALL PARTICIPANTS)
float
C0033684 (UMLS CUI [1,1])
C0042440 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PUFA182
Item
LINOLEIC ACID (PUFA 18:2) (G) (ALL PARTICIPANTS)
float
C0032615 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_SFIB
Item
SOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
float
C0012173 (UMLS CUI [1,1])
C0556108 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_APROT
Item
ANIMAL PROTEIN (G) (ALL PARTICIPANTS)
float
C0033684 (UMLS CUI [1,1])
C3494749 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_SEL
Item
SELENIUM (MCG) (ALL PARTICIPANTS)
float
C0036581 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PUFA
Item
TOTAL POLYUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
C0439810 (UMLS CUI [1,1])
C2700114 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_MUFA
Item
TOTAL MONOUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
C0439810 (UMLS CUI [1,1])
C2700114 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_ALC
Item
ALCOHOL (G) (ALL PARTICIPANTS)
float
C0001948 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_GAL
Item
GALACTOSE (G) (ALL PARTICIPANTS)
float
C0016945 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_LACT
Item
LACTOSE (G) (ALL PARTICIPANTS)
float
C0022949 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_IFIB
Item
INSOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
float
C0012173 (UMLS CUI [1,1])
C1298908 (UMLS CUI [1,2])
C0037633 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_VITD
Item
VITAMIN D (MCG) (ALL PARTICIPANTS)
float
C0042866 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_B12
Item
VITAMIN B12 (MCG) (ALL PARTICIPANTS)
float
C0042845 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_CU
Item
COPPER (MG) (ALL PARTICIPANTS)
float
C0009968 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
EPA
Item
EICOSAPENTAENOIC ACID (G) (ALL PARTICIPANTS)
float
C0015689 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DHA
Item
DOCOSAHEXAENOIC ACID (G) (ALL PARTICIPANTS)
float
C0015689 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_TRYP
Item
TRYPTOPHAN (G) (ALL PARTICIPANTS)
float
C0041249 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_MET
Item
METHIONINE (G) (ALL PARTICIPANTS)
float
C0025646 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_GLUT
Item
GLUTAMIN ACID (G) (ALL PARTICIPANTS)
float
C0017797 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PUFA183
Item
LINOLENIC ACID (G) (ALL PARTICIPANTS)
float
C0015689 (UMLS CUI [1,1])
C2700114 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DT_PUFA204
Item
ARACHIDONIC ACID (G) (ALL PARTICIPANTS)
float
C0003695 (UMLS CUI [1,1])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
FFQTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF FOLLOW-UP ASSESSMENT (If available) (ALL PARTICIPANTS)
float
C0439234 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C3694716 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DGL
Item
DIETARY GLYCEMIC LOAD (ALL PARTICIPANTS)
float
C3267174 (UMLS CUI [1,1])
C0012155 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
DGI
Item
DIETARY GLYCEMIC INDEX (ALL PARTICIPANTS)
float
C1136206 (UMLS CUI [1,1])
C0012155 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
TACHO
Item
TOTAL AVAILABLE DIETARY CARBOHYDRATES (G) (ALL PARTICIPANTS)
float
C0439810 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0007004 (UMLS CUI [1,3])
C0012155 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Ritorna all'inizio della pagina